Rilmenidine attenuates toxicity of polyglutamine expansions in a mouse model of Huntington's disease

By Rose Claudia   Menzies Fiona M.   Renna Maurizio   Acevedo-Arozena Abraham   Corrochano Silvia   Sadiq Oana   Brown Steve D.   Rubinsztein David C.  

Human Molecular Genetics, Vol. 19, Iss. 11, 2010-06 ,pp. : 2144-2153

Oxford University Press

Access to resources Recommend Favorite

Increased huntingtin protein length reduces the number of polyglutamine-induced gene expression changes in mouse models of Huntington's disease

By Chan Edmond Y.W.  

Human Molecular Genetics, Vol. 11, Iss. 17, 2002-06 ,pp. : 1939-1951

Oxford University Press

Access to resources Recommend Favorite

Transgenic rat model of Huntington's disease

By Krotova J.  

Human Molecular Genetics, Vol. 12, Iss. 6, 2003-03 ,pp. : 617-624

Oxford University Press

Access to resources Recommend Favorite

An ovine transgenic Huntington's disease model

By Jacobsen Jessie C.   Bawden C. Simon   Rudiger Skye R.   McLaughlan Clive J.   Reid Suzanne J.   Waldvogel Henry J.   MacDonald Marcy E.   Gusella James F.   Walker Simon K.   Kelly Jennifer M.   Webb Graham C.   Faull Richard L.M.   Rees Mark I.   Snell Russell G.  

Human Molecular Genetics, Vol. 19, Iss. 10, 2010-05 ,pp. : 1873-1882

Oxford University Press

Access to resources Recommend Favorite

Altered serotonin receptor expression is associated with depression-related behavior in the R6/1 transgenic mouse model of Huntington's disease

By Pang Terence Y.C.   Du Xin   Zajac Michelle S.   Howard Monique L.   Hannan Anthony J.  

Human Molecular Genetics, Vol. 18, Iss. 4, 2009-02 ,pp. : 753-766

Oxford University Press

Access to resources Recommend Favorite